<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35052424</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>29</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Heterozygous <i>DHTKD1</i> Variants in Two European Cohorts of Amyotrophic Lateral Sclerosis Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">84</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes13010084</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive upper and lower motor neuron (LMN) loss. As ALS and other neurodegenerative diseases share genetic risk factors, we performed whole-exome sequencing in ALS patients focusing our analysis on genes implicated in neurodegeneration. Thus, variants in the <i>DHTKD1</i> gene encoding dehydrogenase E1 and transketolase domain containing 1 previously linked to 2-aminoadipic and 2-oxoadipic aciduria, Charcot-Marie-Tooth (CMT) disease type 2, and spinal muscular atrophy (SMA) were identified. In two independent European ALS cohorts (<i>n</i> = 643 cases), 10 sporadic cases of 225 (4.4%) predominantly sporadic patients of cohort 1, and 12 familial ALS patients of 418 (2.9%) ALS families of cohort 2 harbored 14 different rare heterozygous <i>DHTKD1</i> variants predicted to be deleterious. Four <i>DHTKD1</i> variants were previously described pathogenic variants, seven were recurrent, and eight were located in the E1_dh dehydrogenase domain. Nonsense variants located in the E1_dh domain were significantly more prevalent in ALS patients versus controls. The phenotype of ALS patients carrying <i>DHTKD1</i> variants partially overlapped with CMT and SMA by presence of sensory impairment and a higher frequency of LMN-predominant cases. Our results argue towards rare heterozygous <i>DHTKD1</i> variants as potential contributors to ALS phenotype and, possibly, pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Osmanovic</LastName><ForeName>Alma</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6012-8423</Identifier><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Essen Center for Rare Diseases (EZSE), University Hospital Essen, 45147 Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gogol</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martens</LastName><ForeName>Helge</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7294-3476</Identifier><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Widjaja</LastName><ForeName>Maylin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, 89070 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schreiber-Katz</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-5621-4487</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feuerhake</LastName><ForeName>Friedrich</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-1234-982X</Identifier><AffiliationInfo><Affiliation>Department of Neuropathology, Institute of Pathology, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langhans</LastName><ForeName>Claus-Dieter</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>GCMS Laboratory, Dietmar Hopp Metabolic Center, University Children's Hospital, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7165-7294</Identifier><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Neurosciences, Ume&#xe5; University, 90185 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, 89070 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weishaupt</LastName><ForeName>Jochen H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, 89070 Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division for Neurodegenerative Diseases, Department of Neurology, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brand</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petri</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Ruthild G</ForeName><Initials>RG</Initials><Identifier Source="ORCID">0000-0001-6610-1080</Identifier><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.2.4.2</RegistryNumber><NameOfSubstance UI="C578281">DHTKD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.2.4.2</RegistryNumber><NameOfSubstance UI="D007655">Ketoglutarate Dehydrogenase Complex</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="Y">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007655" MajorTopicYN="N">Ketoglutarate Dehydrogenase Complex</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2-aminoadipic and 2-oxoadipic aciduria</Keyword><Keyword MajorTopicYN="N">Charcot-Marie-Tooth disease type 2</Keyword><Keyword MajorTopicYN="N">DHTKD1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">lower motor neuron</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">whole-exome sequencing</Keyword></KeywordList><CoiStatement>A.O. received honoraria from Biogen; O.S.-K. received honoraria from the German Society for Patients with Neuromuscular Diseases (Deutsche Gesellschaft f&#xfc;r Muskelkranke, DGM), Novartis, Biogen, Biermann Verlag, MK + S&#x2014;Medizin, Kommunikation &amp; Service, and the Jain Foundation outside of this work; F.F. received research funding from iOmx Therapeutics; P.M.A. is consultant to Biogen, Roche, Avrion, Regeneron, and Orphazyme; clinical trial site investigator for Biogen, Alexion, Sanofi, AL-S Pharma, Amylyx, and Orphazyme; since 1993 director of the ALS-FTD genetic laboratory at Ume&#xe5; University Hospital that performs clinical and research genetic testing; member of the ClinGen ALS Gene Curation Expert Panel; S.P. received honoraria from Biogen, Cytokinetics, Desitin Pharma, Novartis, Roche, and Teva. The other authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35052424</ArticleId><ArticleId IdType="pmc">PMC8774751</ArticleId><ArticleId IdType="doi">10.3390/genes13010084</ArticleId><ArticleId IdType="pii">genes13010084</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R.H., Jr., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:1602. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Calvo A., Moglia C., Mazzini L., Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: A population based study. J. Neurol. Neurosurg. Psychiatry. 2011;82:740&#x2013;746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Battistini S., Calvo A., Caponnetto C., Conforti F.L., Corbo M., Giannini F., Mandrioli J., Mora G., Sabatelli M., et al. Genetic counselling in ALS: Facts, uncertainties and clinical suggestions. J. Neurol. Neurosurg. Psychiatry. 2014;85:478&#x2013;485. doi: 10.1136/jnnp-2013-305546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-305546</ArticleId><ArticleId IdType="pubmed">23833266</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.F., Wu Z.Y. Genotype-phenotype correlations of amyotrophic lateral sclerosis. Transl. Neurodegener. 2016;5:3. doi: 10.1186/s40035-016-0050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-016-0050-8</ArticleId><ArticleId IdType="pmc">PMC4738789</ArticleId><ArticleId IdType="pubmed">26843957</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevez-Fraga C., Magrinelli F., Hensman Moss D., Mulroy E., Di Lazzaro G., Latorre A., Mackenzie M., Houlden H., Tabrizi S.J., Bhatia K.P. Expanding the Spectrum of Movement Disorders Associated with C9orf72 Hexanucleotide Expansions. Neurol. Genet. 2021;7:e575. doi: 10.1212/NXG.0000000000000575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000575</ArticleId><ArticleId IdType="pmc">PMC8105892</ArticleId><ArticleId IdType="pubmed">33977144</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanovic A., Widjaja M., F&#xf6;rster A., Weder J., Wattjes M.P., Lange I., Sarikidi A., Auber B., Raab P., Christians A., et al. SPG7 mutations in amyotrophic lateral sclerosis: A genetic link to hereditary spastic paraplegia. J. Neurol. 2020;267:2732&#x2013;2743. doi: 10.1007/s00415-020-09861-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09861-w</ArticleId><ArticleId IdType="pmc">PMC7419373</ArticleId><ArticleId IdType="pubmed">32447552</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayaprolu S., Fujioka S., Traynor S., Soto-Ortolaza A.I., Petrucelli L., Dickson D.W., Rademakers R., Boylan K.B., Graff-Radford N.R., Uitti R.J., et al. TARDBP mutations in Parkinson&#x2019;s disease. Parkinsonism Relat. Disord. 2013;19:312&#x2013;315. doi: 10.1016/j.parkreldis.2012.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2012.11.003</ArticleId><ArticleId IdType="pmc">PMC3582838</ArticleId><ArticleId IdType="pubmed">23231971</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: What do we really know? . Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Danhauser K., Sauer S.W., Haack T.B., Wieland T., Staufner C., Graf E., Zschocke J., Strom T.M., Traub T., Okun J.G., et al. DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria. Am. J. Hum. Genet. 2012;91:1082&#x2013;1087. doi: 10.1016/j.ajhg.2012.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.10.006</ArticleId><ArticleId IdType="pmc">PMC3516599</ArticleId><ArticleId IdType="pubmed">23141293</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagen J., Te Brinke H., Wanders R.J., Knegt A.C., Oussoren E., Hoogeboom A.J., Ruijter G.J., Becker D., Schwab K.O., Franke I., et al. Genetic basis of alpha-aminoadipic and alpha-ketoadipic aciduria. J. Inherit. Metab. Dis. 2015;38:873&#x2013;879. doi: 10.1007/s10545-015-9841-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-015-9841-9</ArticleId><ArticleId IdType="pubmed">25860818</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W.Y., Gu M.M., Sun L.H., Guo W.T., Zhu H.B., Ma J.F., Yuan W.T., Kuang Y., Ji B.J., Wu X.L., et al. A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in a large Chinese pedigree. Am. J. Hum. Genet. 2012;91:1088&#x2013;1094. doi: 10.1016/j.ajhg.2012.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.09.018</ArticleId><ArticleId IdType="pmc">PMC3516600</ArticleId><ArticleId IdType="pubmed">23141294</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakaya M., Storbeck M., Strathmann E.A., Delle Vedove A., H&#xf6;lker I., Altmueller J., Naghiyeva L., Schmitz-Steinkr&#xfc;ger L., Vezyroglou K., Motameny S., et al. Targeted sequencing with expanded gene profile enables high diagnostic yield in non-5q-spinal muscular atrophies. Hum. Mutat. 2018;39:1284&#x2013;1298. doi: 10.1002/humu.23560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23560</ArticleId><ArticleId IdType="pubmed">29858556</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Barohn R.J., Corcia P., Fink J.K., Harms M.B., Kiernan M.C., Ravits J., Silani V., Simmons Z., Statland J., et al. Primary lateral sclerosis: Consensus diagnostic criteria. J. Neurol. Neurosurg. Psychiatry. 2020;91:373&#x2013;377. doi: 10.1136/jnnp-2019-322541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322541</ArticleId><ArticleId IdType="pmc">PMC7147236</ArticleId><ArticleId IdType="pubmed">32029539</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico E., Pasmantier M., Lee Y.W., Weimer L., Mitsumoto H. Clinical evolution of pure upper motor neuron disease/dysfunction (PUMMD) Muscle Nerve. 2013;47:28&#x2013;32. doi: 10.1002/mus.23496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23496</ArticleId><ArticleId IdType="pmc">PMC3528840</ArticleId><ArticleId IdType="pubmed">23169452</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., Nakanishi A. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J. Neurol. Sci. 1999;169:13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Labra J., Menon P., Byth K., Morrison S., Vucic S. Rate of disease progression: A prognostic biomarker in ALS. J. Neurol. Neurosurg. Psychiatry. 2016;87:628&#x2013;632. doi: 10.1136/jnnp-2015-310998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310998</ArticleId><ArticleId IdType="pubmed">26152368</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz R., M&#xfc;ller K., Brenner D., Volk A.E., Borck G., Hermann A., Meitinger T., Strom T.M., Danzer K.M., Ludolph A.C., et al. SQSTM1/p62 variants in 486 patients with familial ALS from Germany and Sweden. Neurobiol. Aging. 2020;87:139.e9&#x2013;139.e15. doi: 10.1016/j.neurobiolaging.2019.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.10.018</ArticleId><ArticleId IdType="pubmed">31859009</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405&#x2013;424. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman L. Organic acid analysis. In: Hommes F.A., editor. Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual. Wiley-Liss; New York, NY, USA: 1991. pp. 143&#x2013;176.</Citation></Reference><Reference><Citation>Hoffmann G., Aramaki S., Blum-Hoffmann E., Nyhan W.L., Sweetman L. Quantitative analysis for organic acids in biological samples: Batch isolation followed by gas chromatographic-mass spectrometric analysis. Clin. Chem. 1989;35:587&#x2013;595. doi: 10.1093/clinchem/35.4.587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/35.4.587</ArticleId><ArticleId IdType="pubmed">2702744</ArticleId></ArticleIdList></Reference><Reference><Citation>Dohrn M.F., Glockle N., Mulahasanovic L., Heller C., Mohr J., Bauer C., Riesch E., Becker A., Battke F., Hortnagel K., et al. Frequent genes in rare diseases: Panel-based next generation sequencing to disclose causal mutations in hereditary neuropathies. J. Neurochem. 2017;143:507&#x2013;522. doi: 10.1111/jnc.14217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14217</ArticleId><ArticleId IdType="pubmed">28902413</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiles A.R., Venturoni L., Mucci G., Elbalalesy N., Woontner M., Goodman S., Abdenur J.E. New Cases of DHTKD1 Mutations in Patients with 2-Ketoadipic Aciduria. JIMD Rep. 2016;25:15&#x2013;19. doi: 10.1007/8904_2015_462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/8904_2015_462</ArticleId><ArticleId IdType="pmc">PMC5059180</ArticleId><ArticleId IdType="pubmed">26141459</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Deignan J.L., Dorrani N., Strom S.P., Kantarci S., Quintero-Rivera F., Das K., Toy T., Harry B., Yourshaw M., et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. J. Am. Med. Assoc. 2014;312:1880&#x2013;1887. doi: 10.1001/jama.2014.14604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.14604</ArticleId><ArticleId IdType="pmc">PMC4278636</ArticleId><ArticleId IdType="pubmed">25326637</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z.H., Chen Z.T., Zhou R.L., Wang Y.Z. A Chinese pedigree with a novel mutation in GJB1 gene and a rare variation in DHTKD1 gene for diverse Charcot-Marie-Tooth diseases. Mol. Med. Rep. 2019;19:4484&#x2013;4490. doi: 10.3892/mmr.2019.10058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.10058</ArticleId><ArticleId IdType="pubmed">30896807</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherrill J.D., Kc K., Wang X., Wen T., Chamberlin A., Stucke E.M., Collins M.H., Abonia J.P., Peng Y., Wu Q., et al. Whole-exome sequencing uncovers oxidoreductases DHTKD1 and OGDHL as linkers between mitochondrial dysfunction and eosinophilic esophagitis. JCI Insight. 2018:3. doi: 10.1172/jci.insight.99922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.99922</ArticleId><ArticleId IdType="pmc">PMC5931135</ArticleId><ArticleId IdType="pubmed">29669943</ArticleId></ArticleIdList></Reference><Reference><Citation>Volk A.E., Weishaupt J.H., Andersen P.M., Ludolph A.C., Kubisch C. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Med. Genet. 2018;30:252&#x2013;258. doi: 10.1007/s11825-018-0185-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11825-018-0185-3</ArticleId><ArticleId IdType="pmc">PMC6132774</ArticleId><ArticleId IdType="pubmed">30220791</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeria N.S., Gerfen G., Nareddy P.R., Yang L., Zhang X., Szostak M., Jordan F. The mitochondrial 2-oxoadipate and 2-oxoglutarate dehydrogenase complexes share their E2 and E3 components for their function and both generate reactive oxygen species. Free Radic. Biol. Med. 2018;115:136&#x2013;145. doi: 10.1016/j.freeradbiomed.2017.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.11.018</ArticleId><ArticleId IdType="pubmed">29191460</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Zhu H., Gu M., Luo Q., Ding J., Yao Y., Chen F., Wang Z. DHTKD1 is essential for mitochondrial biogenesis and function maintenance. FEBS Lett. 2013;587:3587&#x2013;3592. doi: 10.1016/j.febslet.2013.08.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2013.08.047</ArticleId><ArticleId IdType="pubmed">24076469</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten S.A., Armstrong G.A., Lissouba A., Kabashi E., Parker J.A., Drapeau P. Fishing for causes and cures of motor neuron disorders. Dis. Model. Mech. 2014;7:799&#x2013;809. doi: 10.1242/dmm.015719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.015719</ArticleId><ArticleId IdType="pmc">PMC4073270</ArticleId><ArticleId IdType="pubmed">24973750</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T.F., Karydas A., Tran H., Yang D., Petrucelli L., Miller B.L., Almeida S., Gao F.B. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim N.C., Tresse E., Kolaitis R.M., Molliex A., Thomas R.E., Alami N.H., Wang B., Joshi A., Smith R.B., Ritson G.P., et al. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron. 2013;78:65&#x2013;80. doi: 10.1016/j.neuron.2013.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.029</ArticleId><ArticleId IdType="pmc">PMC3683300</ArticleId><ArticleId IdType="pubmed">23498974</ArticleId></ArticleIdList></Reference><Reference><Citation>Auranen M., Ylikallio E., Shcherbii M., Paetau A., Kiuru-Enari S., Toppila J.P., Tyynismaa H. CHCHD10 variant p. (Gly66Val) causes axonal Charcot-Marie-Tooth disease. Neurol. Genet. 2015;1:e1. doi: 10.1212/nxg.0000000000000003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/nxg.0000000000000003</ArticleId><ArticleId IdType="pmc">PMC4821082</ArticleId><ArticleId IdType="pubmed">27066538</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S., Ait-El-Mkadem S., Chaussenot A., Genin E.C., Lacas-Gervais S., Fragaki K., Berg-Alonso L., Kageyama Y., Serre V., Moore D.G., et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137:2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschbach J., Sinniger J., Bouitbir J., Fergani A., Schlagowski A.I., Zoll J., Geny B., Ren&#xe9; F., Larmet Y., Marion V., et al. Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age. Neurobiol. Dis. 2013;58:220&#x2013;230. doi: 10.1016/j.nbd.2013.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.05.015</ArticleId><ArticleId IdType="pmc">PMC3748180</ArticleId><ArticleId IdType="pubmed">23742762</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentis A.F., Vlachakis D., Papakonstantinou E., Zaganas I., Patrinos G.P., Chrousos G.P., Dardiotis E. A novel variant in DYNC1H1 could contribute to human amyotrophic lateral sclerosis-frontotemporal dementia spectrum. Cold Spring Harb. Mol. Case Stud. 2021:mcs-a006096. doi: 10.1101/mcs.a006096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/mcs.a006096</ArticleId><ArticleId IdType="pubmed">34535505</ArticleId></ArticleIdList></Reference><Reference><Citation>Leandro J., Khamrui S., Wang H., Suebsuwong C., Nemeria N.S., Huynh K., Moustakim M., Secor C., Wang M., Dodatko T., et al. Inhibition and Crystal Structure of the Human DHTKD1-Thiamin Diphosphate Complex. ACS Chem. Biol. 2020;15:2041&#x2013;2047. doi: 10.1021/acschembio.0c00114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.0c00114</ArticleId><ArticleId IdType="pmc">PMC7890914</ArticleId><ArticleId IdType="pubmed">32633484</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Nemeria N.S., Leandro J., Houten S., Lazarus M., Gerfen G., Ozohanics O., Ambrus A., Nagy B., Brukh R., et al. Structure-function analyses of the G729R 2-oxoadipate dehydrogenase genetic variant associated with a disorder of l-lysine metabolism. J. Biol. Chem. 2020;295:8078&#x2013;8095. doi: 10.1074/jbc.RA120.012761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.012761</ArticleId><ArticleId IdType="pmc">PMC7278340</ArticleId><ArticleId IdType="pubmed">32303640</ArticleId></ArticleIdList></Reference><Reference><Citation>Leandro J., Dodatko T., Aten J., Nemeria N.S., Zhang X., Jordan F., Hendrickson R.C., Sanchez R., Yu C., DeVita R.J., et al. DHTKD1 and OGDH display substrate overlap in cultured cells and form a hybrid 2-oxo acid dehydrogenase complex in vivo. Hum. Mol. Genet. 2020;29:1168&#x2013;1179. doi: 10.1093/hmg/ddaa037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa037</ArticleId><ArticleId IdType="pmc">PMC7206849</ArticleId><ArticleId IdType="pubmed">32160276</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel S.H. Is ALS a systemic disorder? Evidence from muscle mitochondria. Exp. Neurol. 2006;198:1&#x2013;3. doi: 10.1016/j.expneurol.2005.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2005.12.025</ArticleId><ArticleId IdType="pubmed">16458887</ArticleId></ArticleIdList></Reference><Reference><Citation>Crugnola V., Lamperti C., Lucchini V., Ronchi D., Peverelli L., Prelle A., Sciacco M., Bordoni A., Fassone E., Fortunato F., et al. Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Arch. Neurol. 2010;67:849&#x2013;854. doi: 10.1001/archneurol.2010.128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.128</ArticleId><ArticleId IdType="pubmed">20625092</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W.Y., Zhu H., Shen Y., Wan Y.H., Tu X.D., Wu W.T., Tang L., Zhang H.X., Lu S.Y., Jin X.L., et al. DHTKD1 Deficiency Causes Charcot-Marie-Tooth Disease in Mice. Mol. Cell. Biol. 2018:38. doi: 10.1128/MCB.00085-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00085-18</ArticleId><ArticleId IdType="pmc">PMC6002691</ArticleId><ArticleId IdType="pubmed">29661920</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Hardiman O. The epidemiology of ALS: A conspiracy of genes, environment and time. Nat. Rev. Neurol. 2013;9:617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., van Es M.A., Hennekam E.A., Dooijes D., van Rheenen W., Medic J., Bourque P.R., Schelhaas H.J., van der Kooi A.J., de Visser M., et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012;21:3776&#x2013;3784. doi: 10.1093/hmg/dds199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds199</ArticleId><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>Weedon M.N., Hastings R., Caswell R., Xie W., Paszkiewicz K., Antoniadi T., Williams M., King C., Greenhalgh L., Newbury-Ecob R., et al. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am. J. Hum. Genet. 2011;89:308&#x2013;312. doi: 10.1016/j.ajhg.2011.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2011.07.002</ArticleId><ArticleId IdType="pmc">PMC3155164</ArticleId><ArticleId IdType="pubmed">21820100</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez M.A., Feely S.M., Speziani F., Strickland A.V., Danzi M., Bacon C., Lee Y., Chou T.F., Blanton S.H., Weihl C.C., et al. A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease. Brain. 2014;137:2897&#x2013;2902. doi: 10.1093/brain/awu224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu224</ArticleId><ArticleId IdType="pmc">PMC4208462</ArticleId><ArticleId IdType="pubmed">25125609</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>